Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
BMC Surg ; 22(1): 23, 2022 Jan 22.
Artículo en Inglés | MEDLINE | ID: mdl-35065651

RESUMEN

BACKGROUND: Portal vein shunt is common in chronic hepatic diseases and after a liver transplant. Ensuring a satisfactory portal flow is essential to support a rapid liver recovery, of paramount importance to meet the recipient's metabolic needs. CASE PRESENTATION: We report the case of a 32-year-old female undergoing a third liver transplant due to recurrence of graft failure secondary to portosystemic shunting. The patient, affected with biliary atresia, was first transplanted in 2009 with a right split liver graft. The clinical course was complicated by biliary stenosis of the Roux-en-Y anastomosis and multiple episodes of acute rejection treated with steroid boluses, plastic dilation of the biliary anastomosis, and biliary catheter placement. Unfortunately, in 2017 a liver biopsy showed an autoimmunity with histological evidence of ANA 1:80 (granular and nucleolar pattern). This was a contributing factor of liver function impairment, leading to the need to perform a second liver transplant, complicated by an acute rejection, with only a partial response to steroid therapy. Due to the further worsening of the liver function (MELD: 40, Child-Pugh: C11), the patient was relisted for a liver transplant. After five days, she received her third liver transplant, with an entire graft of an AB0 identical group. Intraoperative exploration revealed multiple collaterals and large splenocaval shunts, with a significant alteration of the portal flow and hypertension, isolated and closed with a vascular stapler to restore the graft's regular portal vein flow. CONCLUSIONS: In patients listed for a liver transplant, portal steal syndrome should be identified prior to the transplant. Our recommendation is to consider intraoperative or perioperative closure of the portal collateral varices.


Asunto(s)
Atresia Biliar , Hepatopatías , Trasplante de Hígado , Enfermedades Vasculares , Adulto , Femenino , Humanos , Vena Porta/cirugía
2.
BMC Surg ; 21(1): 44, 2021 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-33468113

RESUMEN

BACKGROUND: One of the major issues related to the living donor liver transplantation recipient outcome is still the high rate of biliary complication, especially when multiple biliary ducts are present and multiple anastomoses have to be performed. CASE PRESENTATION AND CONCLUSION: We report a case of adult-to-adult right lobe living donor liver transplantation performed for a recipient affected by alcohol-related cirrhosis with MELD score of 17. End-stage liver disease was complicated by refractory ascites, portal hypertension, small esophageal varices and portal gastropathy, hypersplenism, and abundant right pleural effusion. Here in the attached video we described the adult-to-adult LDLT procedures, where a right lobe with two biliary ducts draining respectively the right anterior and the right posterior segments has been transplanted. LDLT required a biliary reconstruction using the native cystic and common bile ducts stented trans-papillary with two 5- French 6 cm long soft silastic catheter. None major complications were detected during post-operative clinical courses. Actually, the donor and the recipient are alive and well. The technique we describe in the video, allow to keep the biliary anastomoses protected and patent without having the risk of creating cholestasis and the need of invasive additional procedure. No living donor right lobe transplantation should be refused because of the presence of multiple biliary ducts.


Asunto(s)
Conductos Biliares/cirugía , Conducto Cístico/cirugía , Cirrosis Hepática Alcohólica/cirugía , Trasplante de Hígado , Donadores Vivos , Stents , Anastomosis Quirúrgica , Conducto Colédoco , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
3.
BMC Surg ; 18(1): 122, 2018 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-30587165

RESUMEN

BACKGROUND: Liver transplantation is the best treatment for end-stage liver disease. The interruption of the blood supply to the donor liver during cold storage damages the liver, affecting how well the liver will function after transplant. The drug Simvastatin may help to protect donor livers against this damage and improve outcomes for transplant recipients. The aim of this study is to evaluate the benefits of treating the donor liver with Simvastatin compared with the standard transplant procedure. PATIENT AND METHODS: We propose a prospective, double-blinded, randomized phase 2 study of 2 parallel groups of eligible adult patients. We will compare 3-month, 6-month, and 12-month graft survival after LT, in order to identify a significant relation between the two homogenous groups of LT patients. The two groups only differ by the Simvastatin or placebo administration regimen while following the same procedure, with identical surgical instruments, and medical and nursing skilled staff. To reach these goals, we determined that we needed to recruit 106 patients. This sample size achieves 90% power to detect a difference of 14.6% between the two groups survival using a one-sided binomial test. DISCUSSION: This trial is designed to confirm the effectiveness of Simvastatin to protect healthy and steatotic livers undergoing cold storage and warm reperfusion before transplantation and to evaluate if the addition of Simvastatin translates into improved graft outcomes. TRIAL REGISTRATION: ISRCTN27083228 .


Asunto(s)
Trasplante de Hígado/métodos , Daño por Reperfusión/prevención & control , Simvastatina/administración & dosificación , Método Doble Ciego , Hígado Graso/patología , Humanos , Hígado/patología , Estudios Prospectivos , Sustancias Protectoras/administración & dosificación
4.
Int J Mol Sci ; 19(10)2018 Sep 27.
Artículo en Inglés | MEDLINE | ID: mdl-30261687

RESUMEN

A certain number of studies were carried out to address the question of how dysbiosis could affect the onset and development of rheumatoid arthritis (RA), but little is known about the reciprocal influence between microbiota composition and immunosuppressive drugs, and how this interaction may have an impact on the clinical outcome. The aim of this study was to characterize the intestinal microbiota in a groups of RA patients treatment-naïve, under methotrexate, and/or etanercept (ETN). Correlations between the gut microbiota composition and validated immunological and clinical parameters of disease activity were also evaluated. In the current study, a 16S analysis was employed to explore the gut microbiota of 42 patients affected by RA and 10 healthy controls. Disease activity score on 28 joints (DAS-28), erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, anti-cyclic citrullinated peptides, and dietary and smoking habits were assessed. The composition of the gut microbiota in RA patients free of therapy is characterized by several abnormalities compared to healthy controls. Gut dysbiosis in RA patients is associated with different serological and clinical parameters; in particular, the phylum of Euryarchaeota was directly correlated to DAS and emerged as an independent risk factor. Patients under treatment with ETN present a partial restoration of a beneficial microbiota. The results of our study confirm that gut dysbiosis is a hallmark of the disease, and shows, for the first time, that the anti-tumor necrosis factor alpha (TNF-α) ETN is able to modify microbial communities, at least partially restoring a beneficial microbiota.


Asunto(s)
Antirreumáticos/efectos adversos , Artritis Reumatoide/microbiología , Disbiosis/etiología , Etanercept/efectos adversos , Microbioma Gastrointestinal/efectos de los fármacos , Antirreumáticos/farmacología , Antirreumáticos/uso terapéutico , Artritis Reumatoide/tratamiento farmacológico , Disbiosis/microbiología , Etanercept/farmacología , Etanercept/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad
5.
Int J Mol Sci ; 18(5)2017 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-28531111

RESUMEN

Carcinosarcomas (CS) in gynecology are very infrequent and represent only 2-5% of uterine cancers. Despite surgical cytoreduction and subsequent chemotherapy being the primary treatment for uterine CS, the overall five-year survival rate is 30 ± 9% and recurrence is extremely common (50-80%). Due to the poor prognosis of CS, new strategies have been developed in the last few decades, targeting known dysfunctional molecular pathways for immunotherapy. In this paper, we aimed to gather the available evidence on the latest therapies for the treatment of CS. We performed a systematic review using the terms "uterine carcinosarcoma", "uterine Malignant Mixed Müllerian Tumors", "target therapies", "angiogenesis therapy", "cancer stem cell therapy", "prognostic biomarker", and "novel antibody-drug". Based on our results, the differential expression and accessibility of epithelial cell adhesion molecule-1 on metastatic/chemotherapy-resistant CS cells in comparison to normal tissues and Human Epidermal Growth Factor Receptor 2 (HER2) open up new possibilities in the field of target therapy. Nevertheless, future investigations are needed to clarify the impact of these new therapies on survival rate and medium-/long-term outcomes.


Asunto(s)
Carcinosarcoma/tratamiento farmacológico , Tumor Mulleriano Mixto/tratamiento farmacológico , Terapia Molecular Dirigida/métodos , Neoplasias Uterinas/tratamiento farmacológico , Anticuerpos Biespecíficos/uso terapéutico , Biomarcadores de Tumor/antagonistas & inhibidores , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/metabolismo , Carcinosarcoma/patología , Epigénesis Genética , Molécula de Adhesión Celular Epitelial/antagonistas & inhibidores , Molécula de Adhesión Celular Epitelial/genética , Molécula de Adhesión Celular Epitelial/metabolismo , Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/genética , Receptores ErbB/metabolismo , Femenino , Humanos , Inmunoterapia , Tumor Mulleriano Mixto/patología , Neovascularización Patológica , Pronóstico , Tasa de Supervivencia , Neoplasias Uterinas/patología
7.
Updates Surg ; 75(5): 1071-1082, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37209317

RESUMEN

Rare complication of gallstone disease is gallstone ileus. The common location is the small intestine, followed by the stomach. The rarest location is colonic gallstone ileus (CGI). To summarize and define the most appropriate diagnostic methods and therapeutic options for CGI based on the paucity of published data. Literature searches of English-, German-, Spanish-, Italian-, Japanese-, Dutch- and Portuguese language articles included and Italian-language articles using PubMed, EMBASE, Web of Science, The Cochrane Library, and Google Scholar. Additional studies were identified from the references of retrieved studies. 113 cases of CGI were recorded with a male to female patient ratio of 1:2.9. The average patient age was 77.7 years (range 45-95 years). The usual location of stone impaction was the sigmoid colon (85.8%), followed by a descending colon (6.6%), transverse colon (4.7%), rectum (1.9%), and lastly, ascending colon (0.9%). Gallstones ranged from 2 to 10 cm. The duration of symptoms was variable (1 day to 2 months), with commonly reported abdominal distension, obstipation, and vomiting; 85.2% of patients had previous biliary symptoms. Diverticular disease was present in 81.8% of patients. During the last 23 years, CT scan was the most common imaging method (91.5%), confirming the ectopic gallstone in 86.7% of cases, pneumobilia in 65.3%, and cholecytocolonic fistula in 68%. The treatment option included laparotomy with cololithotomy and primary closure (24.7%), laparotomy and cololithotomy with diverting stoma (14.2%), colonic resection with anastomosis (7.9%), colonic resection with a colostomy (12.4%), laparoscopy with cololithotomy with primary closure (2.6%), laparoscopy with cololithotomy with a colostomy (0.9%), colostomy without gallstone extraction (5.3%), endoscopic mechanical lithotripsy (success rate 41.1%), extracorporeal shock wave lithotripsy (1.8%). The cholecystectomy rate was 46.7%; during the initial procedure 25%, and as a separate procedure, 21.7%; 53.3% of patients had no cholecystectomy. The survival rate was 87%. CGI is the rarest presentation of gallstone ileus, mainly in women over 70 years of age, with gallstones over 2 cm, and predominantly in the sigmoid colon. Abdominal CT is diagnostic. Nonoperative treatment, particularly in subacute presentations, should be the first-line treatment. Laparotomy with cololithotomy or colonic resection is a standard procedure with favorable outcomes. There are no robust data on whether primary or delayed cholecystectomy is mandatory as a part of CGI management.


Asunto(s)
Cálculos Biliares , Ileus , Obstrucción Intestinal , Enfermedades del Sigmoide , Humanos , Femenino , Masculino , Anciano , Anciano de 80 o más Años , Persona de Mediana Edad , Cálculos Biliares/complicaciones , Cálculos Biliares/diagnóstico , Cálculos Biliares/cirugía , Ileus/diagnóstico , Ileus/etiología , Ileus/cirugía , Enfermedades del Sigmoide/cirugía , Obstrucción Intestinal/etiología , Algoritmos
8.
Biosci Trends ; 17(3): 203-210, 2023 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-37344395

RESUMEN

The match between donor and recipient (D-R match) in the field of liver transplantation (LT) is one of the most widely debated topics today. Within the cohort of patients waiting for a transplant, better matching of the donor organ to the recipient will improve transplant outcomes, and benefit the waiting list by minimizing graft failure and the need for re-transplantation. In an era of suboptimal matches due to the sparse organ pool and the increase in extended criteria donors (ECD), ensuring adequate outcomes becomes the primary goal for clinicians in the field. The objective of this mini-review is to analyze the main variables in the evaluation of the D-R match to ensure better outcomes, the existence of scores that can help in the realization of this match, and the latest advances made thanks to the technology and development of artificial intelligence (AI).


Asunto(s)
Trasplante de Hígado , Trasplantes , Humanos , Adulto , Inteligencia Artificial , Supervivencia de Injerto , Donantes de Tejidos
9.
Front Cardiovasc Med ; 10: 1151803, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37025682

RESUMEN

Transthyretin related cardiac amyloidosis (TTR-CA) is an infiltrative cardiomyopathy that cause heart failure with preserved ejection fraction, mainly in aging people. Due to the introduction of a non invasive diagnostic algorithm, this disease, previously considered to be rare, is increasingly recognized. The natural history of TTR-CA includes two different stages: a presymptomatic and a symptomatic stage. Due to the availability of new disease-modifying therapies, the need to reach a diagnosis in the first stage has become impelling. While in variant TTR-CA an early identification of the disease may be obtained with a genetic screening in proband's relatives, in the wild-type form it represents a challenging issue. Once the diagnosis has been made, in order to identifying patients with a higher risk of cardiovascular events and death it is necessary to focus on risk stratification. Two prognostic scores have been proposed both based on biomarkers and laboratory findings. However, a multiparametric approach combining information from electrocardiogram, echocardiogram, cardiopulmonary exercise test and cardiac magnetic resonance may be warranted for a more comprehensive risk prediction. In this review, we aim at evaluating a step by step risk stratification, providing a clinical diagnostic and prognostic approach for the management of patients with TTR-CA.

10.
J Clin Med ; 12(14)2023 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-37510901

RESUMEN

BACKGROUND: Ischemia/reperfusion injury (IRI), acute rejection (AR), and delayed graft function (DGF) might occur as major complications following kidney transplantation. Thus, the identification of biomarkers for the IRI, AR, and/or DGF development becomes crucial as it may help to guide post-transplant management. Natural killer (NK) cells, hepatic interstitial T-lymphocytes (T-Li), and NK-T cells are crucial in both innate and adaptive immunity after abdominal solid organ transplantation. Hence, the aim of this study was to evaluate the impact of the immune system after graft reperfusion during KT in adults in order to identify predictive biomarkers. METHODS: The NK, T-Li, and NK-T phenotypes and concentrations were retrospectively analyzed in a consecutive series of liver perfusates obtained after organ procurement flushing the abdominal cavity recovered from deceased brain donors (DBDs). Their percentage was compared with the renal transplant recipients' characteristics with kidneys taken from the same DCDs. The hepatic perfusate cells were purified by density gradient centrifugation. Flow cytometric investigation was used to determine their phenotype with the following immunological markers in order to determine the relative percentage of T-Li, NK-T, and NK cells: CD3, CD4, CD8, and CD56. RESULTS: 42 DBDs' liver perfusates were analyzed. The related clinical outcomes of kidney transplant recipients from 2010 to 2020 performed at our Institute were evaluated. Time in days of delayed functional recovery of transplanted kidneys (DGF) (p = 0.02) and the onset of secondary infection from a cytomegalovirus (p = 0.03) were significantly associated with the T-Li percentage. An increased relative risk (HR) of organ survival was significantly associated with the percent cell concentration of T-Li and time to DGF, on COX analysis, were (HR = 1.038, p = 0.04; and HR = 1.029, p = 0.01, respectively). None relevant clinical outcomes in kidney transplant patients were associated with the specificity of the NK and NK-T cell proportions. CONCLUSIONS: A new potential role of T-Li cells was detected in the context of hepatic perfusate from DBDs. It could detect potential impacts in organ allocation, surgical procuring techniques, and in the analysis of IRI pathophysiological events.

11.
Updates Surg ; 74(3): 843-855, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35366181

RESUMEN

In the last decade, Ultra-minimally invasive surgery (UMIS) including both minilaparoscopic (MH) and percutaneous (PH) endoscopic surgery achieved widespread use around the world. Despite UMIS has been reported as safe and feasible surgical procedure, most of the available data are drawn from retrospective studies, with a limited number of cases and heterogeneous surgical procedures included in the analysis. This literature review aimed to analyze the most methodologically valid studies concerning major gynecological surgeries performed in UMIS. A literature review was performed double blind from January to April 2021. The keywords 'minilaparoscopy'; 'ultra minimally invasive surgery'; '3 mm'; 'percutaneous'; and 'Hysterectomy' were selected in Pubmed, Medscape, Scopus, and Google scholar search engines. PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines were followed for the drafting of the systematic review. The systematic literature research provided 298 studies, of which 9 fell within the inclusion criteria. Two hundred ninety-six total patients were included, 148 for both PH and MH groups. Median age (48 years), BMI (24 kg/m2), OT (90 min), EBL (50 ml), time to discharge (1 day), self scar evaluation (10/10), and VAS (3/10) were reported. The most frequent intraoperative complication in both the PH and MH groups was surgical bleeding. The UMIS approaches were feasible and safe even for complex gynecological procedures. Operative times and complications were superimposable to the "classical" minimally invasive approaches reported in the literature. The reported results apply only to experienced surgeons.


Asunto(s)
Histerectomía , Procedimientos Quirúrgicos Mínimamente Invasivos , Femenino , Procedimientos Quirúrgicos Ginecológicos , Humanos , Histerectomía/métodos , Persona de Mediana Edad , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Tempo Operativo , Ensayos Clínicos Controlados Aleatorios como Asunto , Estudios Retrospectivos
12.
Updates Surg ; 74(6): 1933-1941, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36048362

RESUMEN

Several scoring systems exist for the management of acute appendicitis (AA) during pregnancy. However, the systems are based on the nonpregnant adult population. The aim of this study was to create a highly accurate scoring system that can be applied to pregnant women and to compare it to the most commonly used scores in general population and pregnant women. The creation and subsequent implementation of a highly accurate score system could shorten the diagnostic period and minimize the use of (ionizing) diagnostic imaging allowing the selection of the best treatment approach in pregnant patients with acute appendicitis. A single-center, retrospective cohort observational study was conducted at the University Hospital Centre Zagreb, Zagreb, Croatia. Data were extracted from medical records of pregnant patients with suspected AA from January 2010 to December 2020. A total of 59 pregnant patients diagnosed with AA during pregnancy were identified, 41 were treated surgically, and 18 had non-surgical management. The main objective of our study was the detection of predictive factors of AA during pregnancy. Anorexia, pain migration to the right lower quadrant, rebound pain, axillary temperature over 37.3 °C, CRP/platelet ratio > 0.0422, neutrophil/lymphocyte ratio > 7.182, and ultrasonic signs of AA were scored. Scoring in Appendicitis TriMOdal Score (ATMOS) consists of positive clinical parameter, each bringing 1 point and other parameters mentioned above that bring 2 points each. The score ranges from 0 to 10. Our model of ATMOS yields a high area under the receiver-operating characteristic curve of 0.963. The positive likelihood ratio is 9.97 (95% CI 2.64-38.00), and the negative likelihood ratio is 0.1 (95% CI 0.03-0.31), meaning that 94% of cases with ATMOS > 4 have AA, while less than 13% with an ATMOS ≤ 4 have the diagnosis of AA. The potential of ATMOS differentiating AA during pregnancy was demonstrated. Future prospective, randomized trials are needed to evaluate its accuracy and whether it should be used instead of Alvarado or Tzanakis scores in clinical decision-making.Trial registration number ClinicalTrials.gov-NCT05202483. Date of registration: January 21, 2022.


Asunto(s)
Cavidad Abdominal , Apendicitis , Humanos , Femenino , Embarazo , Adulto , Apendicitis/diagnóstico , Apendicitis/cirugía , Estudios Retrospectivos , Enfermedad Aguda , Dolor
13.
Updates Surg ; 74(1): 193-202, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34542843

RESUMEN

The use of expanded criteria donors is one of the strategies used to overcome the gap between the demand for organs and the number of donors. Physicians debate the extent to which marginal grafts can be used. In recent years, normothermic machine perfusion (NMP) has been used to test liver viability before transplantation. Grafts underwent NMP whenever histological steatosis was > 40% or there were at least three Eurotransplant criteria for expanded criteria donor (ECD). We used NMP to test 19 grafts, 3 from donation after type 3 controlled cardiac death (DCD), and 16 from donation after brain death (DBD). Only two grafts from DBD were not transplanted, because perfusion proved they were not suitable (total of 17 transplanted grafts of 19 tested grafts). Kaplan-Meier survival estimates at 30, 90, 180, and 1 year after transplant were all 94% (95% CI 84-100%); estimated 3-years survival was 82% (95% CI 62-100%). Overall survival rates did not differ from those of patients transplanted with non-perfused grafts from an ECD. In our experience, the use of very marginal grafts preventively tested by NMP does not negatively influence the patient's outcome, and increases the number of transplants in low donation areas.


Asunto(s)
Supervivencia de Injerto , Preservación de Órganos , Aloinjertos , Humanos , Hígado , Perfusión , Donantes de Tejidos
14.
Updates Surg ; 73(3): 1155-1167, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32472402

RESUMEN

Since the first robotic single-site hysterectomy was performed, the research focused on the use of robotic single-site surgery (RSSS) for all gynecological conditions. This review aims to examine the studies available in the literature on RSSS in gynecology both for benign and malignant indications. The systematic review was carried out in agreement with the preferred reporting items for systematic reviews and meta-analyses statement (PRISMA). All the articles were grouped into three sets based on the surgical indication (Group 1, 2, and 3 for benign, malignant, and mixed diseases, respectively). Two hundred and fifty total studies were analyzed, and 27 articles were included in the review. A total of 1065 patients were included in the analysis. Of these, 605 patients were included in group 1, 260 in group 2, and 200 in group 3. Ten (1.7%) patients with benign pathology, 16 (6.2%) patients with malignant disease, and 5 (2.5%) patients with both diseases developed major complications. Two (0.3%) patients in group 1, 3 (1.2%) patients in group 2 and 5 (2.5%) in group 3 were converted to a different type of surgery. No significant differences were found between groups for BMI (p = 0.235), operative time (p = 0.723), estimated blood loss (EBL) (p = 0.342), and hospital stay (p = 0.146). The complications and conversions incidence through pooled analysis showed a higher general conversion rate (p = 0.012) in group 3 (3.0%) and higher complications rate (p = 0.001) in group 2 (5.3%) compared to the other groups. RSSS seems to be a feasible and safe procedure for all gynecological surgical procedures. A long-term analysis would be necessary before considering the RSSS oncologically safe for patients with malignant disease.


Asunto(s)
Laparoscopía , Procedimientos Quirúrgicos Robotizados , Femenino , Procedimientos Quirúrgicos Ginecológicos , Humanos , Histerectomía , Tempo Operativo
15.
J Clin Med ; 10(8)2021 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-33916967

RESUMEN

While most patients with hypertrophic cardiomyopathy (HCM) show a relatively stable morphologic and clinical phenotype, in some others, progressive changes in the left ventricular (LV) wall thickness, cavity size, and function, defined, overall, as "LV remodeling", may occur. The interplay of multiple pathophysiologic mechanisms, from genetic background to myocardial ischemia and fibrosis, is implicated in this process. Different patterns of LV remodeling have been recognized and are associated with a specific impact on the clinical course and management of the disease. These findings underline the need for and the importance of serial multimodal clinical and instrumental evaluations to identify and further characterize the LV remodeling phenomenon. A more complete definition of the stages of the disease may present a chance to improve the management of HCM patients.

16.
Updates Surg ; 73(6): 2347-2354, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32996053

RESUMEN

To assess the feasibility and the safety of the ultra-minimally invasive (U-MIS) approaches in gynecology, we compared our experience in percutaneous assisted hysterectomy (PSS-H) with a series of 3 mm mini-laparoscopy hysterectomy (m-LPS-H). 126 patients affected by benign and malignant gynecological conditions were considered eligible for minimally invasive hysterectomy: 80 patients received PSS approach and 46 m-LPS approach. For both groups, we evaluated intra and perioperative outcomes, post-operative pain and cosmetic outcomes. The baseline characteristics were comparable between the two study groups. As well, no differences were reported in the clinical indications for hysterectomy, principally fibroids/adenomyosis, endometrial hyperplasia and early stage endometrial cancer. The median operative time was 88.5 (40-190) minutes for PSS-H group and 95.0 (42-231) minutes in m-LPS-H group (p = 0.131). No differences were detected in median estimated blood loss (p = 0.104) as well, in the uterine manipulator usage (p = 0.127) between the two different surgical approaches. Only 1 (2.2%) conversion to standard laparoscopy occurred in m-LPS-H group (p = 0.691). One intra-operative complication was recorded 1 (1.3%) in the PSS-H group (p = 0.367). The post-operative early complication was recorded in five cases of PSS-H group (p = 0.158), none for m-LPS-H procedures. The results in post-operative pain detection was statistically significant after 4 h in favor of m-LPS-H group (p = 0.001). After 30 days no differences in cosmetic satisfaction were detected between the two groups (p = 0.206). PSS-H and m-LPS-H are two valid U-MIS alternatives for benign gynecological conditions and low/intermediate risk endometrial cancer.


Asunto(s)
Neoplasias Endometriales , Laparoscopía , Neoplasias Endometriales/cirugía , Femenino , Humanos , Histerectomía , Procedimientos Quirúrgicos Mínimamente Invasivos , Tempo Operativo , Dolor Postoperatorio , Estudios Retrospectivos
17.
Ann Ital Chir ; 81(3): 193-8, 2010.
Artículo en Italiano | MEDLINE | ID: mdl-21105482

RESUMEN

INTRODUCTION: Hernia is a common problem in general surgery practice. Incisional hernia can develop in 15-25% patients after abdominal surgery. The aim of this study is to evaluate the complications of hernia surgery. MATERIALS AND METHODS: A retrospective analysis of database of surgery department from January 2003 to April 2009 has involved 84 patients who were treated in laparoscopy at the General Surgery and Oncology Department of Catania University. Sixty-three cases were incisional hernia, 21 primitive ventral hernia. In 51 cases (64.5%) the Dual Mesh were applied and in 28 (35.4%) the Bard Composix Mesh. Postoperatory complications were classified in early and late ones, respectively according to their occurrence before or after 30 days from surgery. Clinical follow ups were performed at one month and thereafter at quarterly intervals for the first year and then annually. RESULTS: Among the early complications we found that patients treated with the Dual Mesh had an incidence of seroma, 8.9% versus 7.8% if compared to those treated with the Bard Composix. Insignificant was the impact of other early complications related to both types of mesh. Some influence in the onset of complications is BMI, in fact the average of complicated cases were 29.5%, while uncomplicated ones were lower: 25 (p < 0.05). DISCUSSION: In our study we looked at early and late complications that can follow laparoscopic treatment of the parietal defects. We have not found statistically significant differences between the two types of implants, which are nevertheless among the early seroma complications which are found to be more frequent in cases treated with the Dual Mesh. CONCLUSION: During this study we observed a higher incidence of seroma and recurrence in cases treated with Dual Mesh in agreement with data reported in literature.


Asunto(s)
Hernia Ventral/cirugía , Laparoscopía/efectos adversos , Polipropilenos , Mallas Quirúrgicas/efectos adversos , Pared Abdominal/cirugía , Índice de Masa Corporal , Femenino , Humanos , Laparoscopía/métodos , Masculino , Registros Médicos , Persona de Mediana Edad , Obesidad , Estudios Retrospectivos , Factores de Riesgo , Prevención Secundaria , Seroma/etiología , Seroma/cirugía , Resultado del Tratamiento
18.
Ann Ital Chir ; 81(4): 307-10, 2010.
Artículo en Italiano | MEDLINE | ID: mdl-21322275

RESUMEN

AIM OF THE STUDY: Intestinal infarction is caused by secondary ischemic damage due to partial or complete obstruction of blood flow usually of arterial origin. About 50% of acute mesenteric infarctions are due to superior mesenteric artery emboli. Arterial thrombosis are most commonly caused to atherosclerosis, less commonly vasculitis, or hypercoaguable states. Venous thrombosis represents only 5-10% of cases usually associated with an hypercoagulable state, less commonly inflammation, portal hypertension or trauma. Non occlusive ischemia may represent up to 25% of acute mesenteric infarction, and is most commonly associated with shock, cardiac arrhythmia or acute pulmonary edema. MATERIAL AND METHODS: From January 2002 to March 2007, 19 patients with intestinal infarction were treated, at the General Surgery and Oncology Department of Catania University. All patients were submitted to RX direct (RX) and computed tomography (CT). In 94.7% of patients RX has demonstrated clear bowel gaseous distension. Preoperative arteriography was carried out in 15.7%, whereas multislice angio-CT only in 36.8%. Second look laparotomy was executed to evaluate the effectiveness of treatments. RESULTS: In 2/19 (10.5%) embolectomy of superior mesenteric artery were executed and in one case 30 cm of ileo resection only. In another 10.5% cases a surgical revascolarization of intestinal arteries with an anterograde by-pass technique was carried out. A resection with anastomosis has been necessary in 78.9% but in 26% of these procedures a second look laparotomy was necessary. DISCUSSION: Three months survival was showed in 36.8% of patients. Completion angiography showed successful recanalization of the superior mesenteric artery without any complication and with satisfactory distal flow. Symptoms of the patients were alleviated. CONCLUSION: Mesenteric ischaemia is a relatively uncommon cause of abdominal pain, but one with significant mortality.


Asunto(s)
Infarto , Intestinos/irrigación sanguínea , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Infarto/diagnóstico por imagen , Infarto/cirugía , Masculino , Radiografía
19.
J Gastrointest Surg ; 24(11): 2702, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-32578022

RESUMEN

BACKGROUND: Indocyanine green injected intravenously has been employed in many fields of hepatobiliary surgery such as liver and biliary tree mapping, tumor detection, and graft evaluation in liver transplant. This latter application has, in our opinion, particular potentials when a split liver transplantation is performed 1-3. METHODS: In this study, we used infrared technology to evaluate in real-time the segment 4 region in a recipient of extended right lobe transplantation. Donor data: 50 years old male, brain death, height, 1.70 mt, weight 69 kg; surgical technique employed was in situ standard split liver procurement. Recipient data: 46 years old male, height 1.75 mt; weight 67 k 23 g, affected by cirrhosis secondary HCV infection, with MELD Na 33. Standard orthotopic liver transplantation was performed with indocyanine green intravenous injection at 15 min after arterial reperfusion. RESULTS: Infrared technology, showed in this video, demonstrates progressive improvement of segment IV viability which was confirmed by the post-operative contrast-enhanced CT scan performed before discharge. The transplant procedure was uneventful and the patient discharged to home 10 days after surgery. CONCLUSION: The case reported in this video is, to the best of our knowledge, the first in the English literature showing how near infrared technology has predictive value on the evaluation of a split graft. Fast diffusion of the colorant allows dynamic early evaluation and may confirm the presence of intra-hepatic venous shunt, which will determine a full recovery of the originally ischemic area. On the contrary, a permanent absence of the staining might be predictive of dysfunction.


Asunto(s)
Trasplante de Hígado , Hepatectomía , Humanos , Verde de Indocianina , Hígado , Cirrosis Hepática , Masculino , Persona de Mediana Edad , Tecnología
20.
Updates Surg ; 72(3): 617-637, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32462610

RESUMEN

Pancreatic cystic lesions (PCLs) have been increasingly identified over the past 2 decades due to the widespread use of high-resolution non-invasive abdominal imaging. They cover a vast spectrum, from benign to malignant and invasive lesions, thus they constitute a significant clinical entity. Among PCLs, mucin-producing lesions are those at risk of progression to malignancy. They include mucinous cystic neoplasms (MCN) and intraductal papillary mucinous neoplasms (IPMN). The diagnosis and management of these cystic lesions are a dilemma since there is a significant overlap in the morphology of benign and premalignant lesions. At the moment, there is no single test that will allow a correct diagnosis in all cases. Magnetic resonance (MR) and endoscopic ultrasound (EUS) morphology, with cyst fluid analysis and cytohistology done with EUS-guided procedure are the best techniques that can narrow the differential diagnosis and identify potentially malignant lesions requiring resection from those requiring follow-up only. The purpose of this paper is to present an updated review of MR imaging findings of mucinous PCLs and to provide a new morphological approach that can serve as a practical guide for the diagnosis of these lesions, allowing a more confident characterization and avoiding relevant misdiagnosis. Furthermore, we provide some information about EUS and cystic fluid analysis and cytohistology, since they are diagnostic modalities that radiologists and surgeons should be familiar with.


Asunto(s)
Imagen por Resonancia Magnética/métodos , Quiste Pancreático/diagnóstico por imagen , Anciano , Pancreatocolangiografía por Resonancia Magnética , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA